先天性高胰岛素血症
重氮氧化物
奥曲肽
磺酰脲受体
医学
高胰岛素性低血糖
高胰岛素血症
错义突变
低血糖
儿科
内科学
内分泌学
胰岛素
突变
生长抑素
基因
糖尿病
生物
遗传学
胰岛素抵抗
格列本脲
作者
Chandra Prabha,Shalini Tripathi,Arpita Bhriguvanshi,Mala Kumar
出处
期刊:Case Reports
[BMJ]
日期:2025-05-01
卷期号:18 (5): e264778-e264778
标识
DOI:10.1136/bcr-2024-264778
摘要
Hyperinsulinemic hypoglycaemia (HH) is a heterogeneous disorder causing persistent hypoketotic hypoglycaemia in neonates and infants. Congenital hyperinsulinism (CHI) is a rare cause of HH, resulting from inappropriate insulin secretion by pancreatic β-cells due to genetic defects in key genes, notably ABCC8 and KCNJ11, which encode the SUR1 and Kir6.2 components of the K ATP channels, respectively. We present a case of a neonate with congenital HH with persistent hypoglycaemia since birth, which was managed with high-dose glucose infusions, diazoxide and octreotide. A homozygous pathogenic missense variant, c4253G>A (p.Arg1418His) in Exon 35 of the ABCC8 gene was identified in the neonate, confirming CHI. Despite initial refractoriness to treatment, the infant responded to octreotide therapy, cornstarch and careful management with regular feeds and monitoring, avoiding the need for surgical intervention. This case underscores the critical role of genetic diagnosis and timely management in preventing long-term neurological sequelae.
科研通智能强力驱动
Strongly Powered by AbleSci AI